Healthcare
M&A Advisory
Pharmaceutical
M&A Advisory
Lazard
Full Credential Description
Cadence Pharmaceuticals. United States. Announced Date 11/02/2014. Closed Date 19/03/2014. Deal value: $1300m. Mallinckrodt to Acquire Cadence Pharmaceuticals. Industry: Cadence Pharmaceuticals was a biopharmaceutical company focused on developing and commercializing products for the hospital market.